Apolipoprotein E and cholesterol in aging and disease in the brain

de Chaves, Elena Posse, Narayanaswami, Vasanthy, Christoffersen, Christina, Nielsen, Lars Bo·2008·Future Lipidology
DOI 10.2217/17460875.3.5.505

Cites (327)

Items 201–328 of 328

  1. New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E
    Libeu, Clare Peters, Lund-Katz, Sissel, Phillips, Michael C., Wehrli, Suzanne, Hernáiz, Maria J., Capila, Ishan, Linhardt, Robert J., Raffaı̈, Robert L., Newhouse, Yvonne M., Zhou, Fanyu et al. · 2001 · Journal of Biological Chemistry
  2. APOE influences on neuropsychological function after mild head injury
    Anna E. Sundström, Petter Marklund, L. -G. Nilsson, Marc Cruts, Rolf Adolfsson, Christine Van Broeckhoven, Lars H Nyberg · 2004 · Neurology
  3. Immune response gene expression increases in the aging murine hippocampus
    Akira Terao, Anjali D. Apte-Deshpande, Linda Dousman, Stephen R. Morairty, Barrett P. Eynon, Thomas S. Kilduff, Yvonne R. Freund · 2002 · Journal of Neuroimmunology
  4. Cholesterol synthesis rate in human hippocampus declines with aging
    Thelen, K.M., Falkai, P., Bayer, T.A., Lütjohann, D. · 2006 · Neuroscience Letters
  5. Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction
    Kazuko Aoki, Toshiki Uchihara, Nobuo Sanjo, Ayako Nakamura, Kenji Ikeda, Kuniaki Tsuchiya, Yoshihiro Wakayama · 2003 · Stroke
  6. The C-Terminal Lipid-Binding Domain of Apolipoprotein E Is a Highly Efficient Mediator of ABCA1-Dependent Cholesterol Efflux that Promotes the Assembly of High-Density Lipoproteins
    Charulatha Vedhachalam, Vasanthy Narayanaswami, Nicole Neto, Trudy M. Forte, Michael C. Phillips, Sissel Lund‐Katz, John Kevin Bielicki · 2007 · Biochemistry
  7. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
    Hatters, Danny M., Zhong, Ning, Rutenber, Earl, Weisgraber, Karl H. · 2006 · Journal of Molecular Biology
  8. Uptake of lipoproteins for axonal growth of sympathetic neurons
    Posse de Chaves, Elena I., Vance, Dennis E., Campenot, Robert B., Kiss, Robert S., Vance, Jean E. · 2000 · Journal of Biological Chemistry
  9. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities
    Sabo, T, Lomnitski, L, Nyska, A, Beni, S, Maronpot, R.R, Shohami, E, Roses, A.D, Michaelson, D.M · 2000 · Neuroscience
  10. Rates of cholesterol, ubiquinone, dolichol and dolichyl‐P biosynthesis in rat brain slices
    Magnus Andersson, P. Göran Elmberger, Conny Edlund, Krister Kristensson, Gustav Dallner · 1990 · FEBS Letters
  11. Quantitation of apoE Domains in Alzheimer Disease Brain Suggests a Role for apoE in Aß Aggregation
    Hyun Soon Cho, Bradley T. Hyman, Steven Mark Greenberg, George William Rebeck · 2001 · Journal of Neuropathology & Experimental Neurology
  12. Premorbid effects of APOE on synaptic proteins in human temporal neocortex
    Seth Love, Lai Khai Siew, David Dawbarn, Gordon Keith Wilcock, Yoav Ben‐Shlomo, Shelley Jane Allen · 2005 · Neurobiology of Aging
  13. Regulation of α- and β-secretase activity by oxysterols: Cerebrosterol stimulates processing of APP via the α-secretase pathway
    Daniel Famer, Steve Meaney, Malahat T. Mousavi, Agneta K. Nordberg, Ingemar Björkhem, Milita Crisby · 2007 · Biochemical and Biophysical Research Communications
  14. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease
    Manuel Buttini, Hassibullah Akeefe, Chin Jia Lin, Robert W. Mahley, Robert E. Pitas, Tony Wyss‐Coray, Lennart Mucke · 2000 · Neuroscience
  15. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity
    Marcos A. Marques, Martin Tolar, Judith A.K. Harmony, Keith A. Crutcher · 1996 · Neuroreport
  16. 24S-Hydroxycholesterol: a Marker of Brain Cholesterol Metabolism
    Dieter Lütjohann, Klaus von Bergmann · 2003 · Pharmacopsychiatry
  17. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP V717F transgenic mice
    Irizarry, Michael C., Cheung, Bonnie S., Rebeck, G. William, Paul, Steven M., Bales, Kelly R., Hyman, B. T. · 2000 · Acta Neuropathologica
  18. Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization
    Mark L. Segall, Padmaja Dhanasekaran, Faye Baldwin, G.M. Anantharamaiah, Karl Heinrich Weisgraber, Michael C. Phillips, Sissel Lund‐Katz · 2002 · Journal of Lipid Research
  19. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis
    Isaac Veinbergs, Analisa Everson, Yutaka Sagara, Eliezer Masliah · 2002 · Journal of Neuroscience Research
  20. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study
    E.-L. Helkala, Keijo J. Koivisto, Tuomo Hänninen, Matti Vanhanen, Kari Kervinen, Johanna Kuusisto, Leena Moilanen Mykkänen, Y. Antero Kesäniemi, Markku Laakso, Paavo J. Riekkinen · 1996 · Neuroscience Letters
  21. Two-step Mechanism of Binding of Apolipoprotein E to Heparin
    Futamura, Miho, Dhanasekaran, Padmaja, Handa, Tetsurou, Phillips, Michael C., Lund-Katz, Sissel, Saito, Hiroyuki · 2005 · Journal of Biological Chemistry
  22. Testing times for the “amyloid cascade hypothesis”
    John Hardy · 2002 · Neurobiology of Aging
  23. Apolipoprotein E metabolism in normolipoproteinemic human subjects.
    Gregg, RE, Zech, LA, Schaefer, EJ, Brewer, HB · 1984 · Journal of Lipid Research
  24. An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins
    BERNARD SHORE, Virgie G. Shore, Antone F. Salel, D. T. Mason, ROBERT F. ZELIS · 1974 · Biochemical and Biophysical Research Communications
  25. Conformational Reorganization of the Four-helix Bundle of Human Apolipoprotein E in Binding to Phospholipid
    Lu, Bin, Morrow, Julie A., Weisgraber, Karl H. · 2000 · Journal of Biological Chemistry
  26. Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E
    Saito, Hiroyuki, Dhanasekaran, Padmaja, Baldwin, Faye, Weisgraber, Karl H., Phillips, Michael C., Lund-Katz, Sissel · 2003 · Journal of Biological Chemistry
  27. The association of apolipoprotein E polymorphism with memory: a population based study
    Eeva‐Liisa Helkala, Keijo J. Koivisto, Tuomo Hänninen, Matti Vanhanen, Kari Kervinen, Johanna Kuusisto, Leena Moilanen Mykkänen, Y. Antero Kesäniemi, Markku Laakso, Paavo J. Riekkinen · 1995 · Neuroscience Letters
  28. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3
    Rebeck, G. William, Kindy, Mark, LaDu, Mary Jo · 2002 · Journal of Alzheimer's Disease
  29. Brain Lipoprotein Metabolism and Its Relation to Neurodegenerative Disease
    Marc Danik, Danielle L. Champagne, Caroline Petit-Turcotte, Uwe Beffert, Judes Poirier · 1999 · Critical Reviews in Neurobiology
  30. Alterations in ApoE and ApoJ in Relation to Degeneration and Regeneration in a Mouse Model of Entorhinal Cortex Lesion
    F. White, James A. R. Nicoll, Karen J. Horsburgh · 2001 · Experimental Neurology
  31. Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse–glia affair
    Göritz, Christian, Mauch, Daniela H, Nägler, Karl, Pfrieger, Frank W · 2002 · Journal of Physiology-Paris
  32. ALTERATIONS IN APOLIPOPROTEIN E EXPRESSION DURING AGING AND NEURODEGENERATION
    Eliezer Masliah, Margaret E. Mallory, Isaac Veinbergs, A. L. Miller, William Samuel · 1996 · Progress in Neurobiology
  33. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype
    Shelley Jane Allen, S.H. MacGowan, SJ Tyler, GK Wilcock, Alan Robertson, PH Holden, Stephanie K.F. Smith, D. Dawbarn · 1997 · Neuroscience Letters
  34. Apolipoprotein E, Synaptic Plasticity and Alzheimer's Disease
    Judes Poirier, Anne Minnich, Jean Davignon · 1995 · Annals of Medicine
  35. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat
    Karen J. Horsburgh, James A. R. Nicoll · 1996 · Neuropathology and Applied Neurobiology
  36. β‐Amyloid Peptide Interacts Specifically with the Carboxyl‐Terminal Domain of Human Apolipoprotein E
    Thierry Pillot, Marc Goethals, Jamilla Najib, Christine Labeur, Laurence Lins, Jean Chambaz, Robert Brasseur, Joel S. Vandekerckhove, Maryvonne Rosseneu · 1999 · Journal of Neurochemistry
  37. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice
    H. Hayashi, U. Igbavboa, H. Hamanaka, Mariko Kobayashi, S. Fujita, W. Wood, K. Yanagisawa · 2002 · NeuroReport
  38. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism.
    Acharya, Prathima, Segall, Mark L, Zaiou, Mohamed, Morrow, Julie, Weisgraber, Karl H, Phillips, Michael C, Lund-Katz, Sissel, Snow, Julian · 2002 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  39. Model of Biologically Active Apolipoprotein E Bound to Dipalmitoylphosphatidylcholine
    Peters-Libeu, Clare A., Newhouse, Yvonne, Hatters, Danny M., Weisgraber, Karl H. · 2006 · Journal of Biological Chemistry
  40. Oxidized Monocyte-Derived Macrophages in Aortic Atherosclerotic Lesion from Apolipoprotein E-Deficient Mice and from Human Carotid Artery Contain Lipid Peroxides and Oxysterols
    Irit Maor, Marielle Kaplan, Tony Hayek, Jacob Vaya, Aaron Hoffman, Michael Aviram · 2000 · Biochemical and Biophysical Research Communications
  41. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia.
    Brent J. Small, Hans Basun, Lars Bäckman · 1998 · Psychology and Aging
  42. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
    Valerio Leoni, Marjan Shafaati, Alina Salomon, Miia Kivipelto, Ingemar Björkhem, Lars‐Olof Wahlund · 2006 · Neuroscience Letters
  43. Amyloid excess in Alzheimer's disease: What is cholesterol to be blamed for?
    María Dolores Ledesma, Carlos G. Dotti · 2006 · FEBS Letters
  44. Cholesterol and pathological processes in Alzheimer's disease
    K. Yanagisawa · 2002 · Journal of Neuroscience Research
  45. A Monomeric, Biologically Active, Full-Length Human Apolipoprotein E
    Zhang, Yonghong, Vasudevan, Sheeja, Sojitrawala, Radiya, Zhao, Wentao, Cui, Chunxian, Xu, Chao, Fan, Daping, Newhouse, Yvonne, Balestra, Reeny, Jerome, W. Gray et al. · 2007 · Biochemistry
  46. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.
    Karin Bohnet, Thierry Pillot, Sophie Visvikis‐Siest, Nicole Sabolovic, Gérard Siest · 1996 · Journal of Lipid Research
  47. Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain
    Motoi, Yumiko, Aizawa, Takako, Haga, Seichi, Nakamura, Satoshi, Namba, Yoshio, Ikeda, Kazuhiko · 1999 · Brain Research
  48. Helix Orientation of the Functional Domains in Apolipoprotein E in Discoidal High Density Lipoprotein Particles
    Vasanthy Narayanaswami, J. Nicholas Maiorano, Padmaja Dhanasekaran, Robert O. Ryan, Michael C. Phillips, Sissel Lund‐Katz, William Sean Davidson · 2004 · Journal of Biological Chemistry
  49. A lipid boundary separates APP and secretases and limits amyloid β-peptide generation
    Christoph Kaether, Christian Haass · 2004 · The Journal of Cell Biology
  50. Ultrastructural Localization of Intraneuronal Aβ-Peptide in Alzheimer Disease Brains
    Gómez-Ramos, Pilar, Asunción Morán, M. · 2007 · Journal of Alzheimer's Disease
  51. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice
    Krzywkowski, P., Ghribi, O., Gagné, J., Chabot, C., Kar, S., Rochford, J., Massicotte, G., Poirier, J. · 1999 · Neuroscience
  52. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function.
    Teter, B., Xu, P‐T., Gilbert, J.R., Roses, A.D., Galasko, D., Cole, G.M. · 2002 · Journal of Neuroscience Research
  53. Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization
    Heeren, Joerg, Grewal, Thomas, Laatsch, Alexander, Rottke, Daniel, Rinninger, Franz, Enrich, Carlos, Beisiegel, Ulrike · 2003 · Journal of Biological Chemistry
  54. Differential Generation of High‐Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes
    Jin‐ichi Ito, Li‐Yong Zhang, Michiyo Asai, Shinji Yokoyama · 1999 · Journal of Neurochemistry
  55. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia
    Karen J. Horsburgh, James McCulloch, Margaret Nilsen, Allen D. Roses, James A. R. Nicoll · 2000 · European Journal of Neuroscience
  56. Apolipoprotein E gene mapping and expression: localization of the structural gene to human chromosome 19 and expression of ApoE mRNA in lipoprotein- and non-lipoprotein-producing tissues
    Yen-Chiu Lin-Lee, Fa -Ten Kao, Peter Cheung, Lawrence Chan · 1985 · Biochemistry
  57. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice
    Harm J. Krugers, Monique T Mulder, Jakob Korf, Louis M. Havekes, E. R. de Kloet, Marian Joëls · 1997 · Neuroreport
  58. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders
    Marjan Shafaati, Alina Solomon, Miia Kivipelto, Ingemar Björkhem, Valerio Leoni · 2007 · Neuroscience Letters
  59. Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE e4 allele
    Anna E. Sundström, L-G Nilsson, Marc Cruts, Rolf Adolfsson, Christine Van Broeckhoven, Lars H Nyberg · 2006 · International Psychogeriatrics
  60. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
    Cyril D S Mamotte, Marian Sturm, Jock I. Foo, Frank M. VAN BOCKXMEER, Roger R. Taylor · 1999 · American Journal of Physiology-Endocrinology and Metabolism
  61. Association of apolipoprotein (Apo)E genotype with plasma apo E levels
    Ilona A. Larson, José María Ordovás, Carl DeLuca, James R. Barnard, Giso Feussner, Ernst J. Schaefer · 2000 · Atherosclerosis
  62. Apolipoprotein E knockout mice display procedural deficits in the Morris water maze: analysis of learning strategies in three versions of the task
    Danielle L. Champagne, J.-B Dupuy, Joseph M. Rochford, Judes Poirier · 2002 · Neuroscience
  63. Amyloid β‐Peptide Effects on Synaptosomes from Apolipoprotein E‐Deficient Mice
    Jeffrey N. Keller, Christopher M. Lauderback, David Allan Butterfield, Mark S. Kindy, Jin Yu, William R. Markesbery · 2000 · Journal of Neurochemistry
  64. The low-density lipoprotein receptor: ligands, debates and lore
    Gabby Rudenko, J. Deisenhofer · 2003 · Current Opinion in Structural Biology
  65. Cholesterol metabolism in the brain: importance of 24S-hydroxylation
    Dieter Lütjohann · 2006 · Acta Neurologica Scandinavica
  66. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice
    Cambon, K, Davies, H.A, Stewart, M.G · 2000 · Neuroscience
  67. APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer’s disease diagnosis
    Fukumoto, Hiroaki, Ingelsson, Martin, Gårevik, Nina, Wahlund, Lars-Olof, Nukina, Nobuyuki, Yaguchi, Yoshio, Shibata, Masao, Hyman, Bradley T., Rebeck, G.William, Irizarry, Michael C. · 2003 · Experimental Neurology
  68. Vulnerability of Synaptosomes from ApoE Knock-Out Mice to Structural and Oxidative Modifications Induced by Aβ(1−40): Implications for Alzheimer's Disease
    Christopher M. Lauderback, Janna M. Hackett, Jeffrey N. Keller, Sridhar Varadarajan, Luke I. Szweda, Mark S. Kindy, William R. Markesbery, David Allan Butterfield · 2001 · Biochemistry
  69. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia.
    Brent J. Small, Hans Basun, Lars Bäckman · 1998 · Psychology and Aging
  70. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease
    Hirsch-Reinshagen, Veronica, Wellington, Cheryl L · 2007 · Current Opinion in Lipidology
  71. Lipid Association-induced N- and C-terminal Domain Reorganization in Human Apolipoprotein E3
    Narayanaswami, Vasanthy, Szeto, Samuel S.W., Ryan, Robert O. · 2001 · Journal of Biological Chemistry
  72. Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
    Karl Heinrich Weisgraber, Robert E. Pitas, Robert W. Mahley · 1994 · Current Opinion in Structural Biology
  73. Increased 3-nitrotyrosine in brains of Apo E-deficient mice
    Russell T. Matthews, M. Flint Beal · 1996 · Brain Research
  74. Interaction with Amyloid β Peptide Compromises the Lipid Binding Function of Apolipoprotein E
    Shiori Tamamizu‐Kato, Jenny Krause Cohen, Carolyn B. Drake, Malathi G. Kosaraju, Jessica Drury, Vasanthy Narayanaswami · 2008 · Biochemistry
  75. Absence of central cholinergic deficits in ApoE knockout mice
    R. Anderson, Guy A. Higgins · 1997 · Psychopharmacology
  76. Contributions of the Carboxyl-Terminal Helical Segment to the Self-Association and Lipoprotein Preferences of Human Apolipoprotein E3 and E4 Isoforms
    Sakamoto, Takaaki, Tanaka, Masafumi, Vedhachalam, Charulatha, Nickel, Margaret, Nguyen, David, Dhanasekaran, Padmaja, Phillips, Michael C., Lund-Katz, Sissel, Saito, Hiroyuki · 2008 · Biochemistry
  77. Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans
    Hara, Masumi, Matsushima, Teruhiko, Satoh, Hiroaki, Iso-o, Naoyuki, Noto, Hiroshi, Togo, Masako, Kimura, Satoshi, Hashimoto, Yoshiaki, Tsukamoto, Kazuhisa · 2003 · Arteriosclerosis, Thrombosis, and Vascular Biology
  78. CHOLESTEROL TRANSPORT AND SYNTHESIS IN SPORADIC ALZHEIMER'S DISEASE
    Judes Poirier, E Apolipoprotein · 2005
  79. Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease
    Mahley, Robert, Huang, Yadong, Weisgraber, Karl · 2007 · Current Alzheimer Research
  80. Neurite Degeneration Elicited by Apolipoprotein E Peptides
    Keith A. Crutcher, Moira A. Clay, Samuel A. Scott, Xintian Tian, Martin Tolar, Judith A.K. Harmony · 1994 · Experimental Neurology
  81. Detection of Apolipoprotein E/Dimeric Soluble Amyloid β Complexes in Alzheimer's Disease Brain Supernatants
    Permanne, Bruno, Perez, Cristian, Soto, Claudio, Frangione, Blas, Wisniewski, Thomas · 1997 · Biochemical and Biophysical Research Communications
  82. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma
    Huang, Y, von Eckardstein, A, Wu, S, Assmann, G · 1995 · Journal of Clinical Investigation
  83. Cellular Catabolism of Lipid Poor Apolipoprotein E via Cell Surface LDL Receptor-Related Protein
    Masaaki Narita, David M. Holtzman, Anne M. Fagan, Mary Jo LaDu, Liming Yu, Xianlin Han, Richard W. Gross, Guojun Bu, Alan L. Schwartz · 2002 · The Journal of Biochemistry
  84. Apolipoprotein E represents a potent gene‐based therapeutic target for the treatment of sporadic Alzheimer's disease
    Judes Poirier · 2008 · Alzheimer s & Dementia
  85. Apolipoprotein E Polymorphism Is Not Associated with Longevity or Disability in a Sample of Italian Octo- and Nonagenarians
    Giovanni Bader, Giovanni Zuliani, Gerhard Max Kostner, R. Fellin · 1998 · Gerontology
  86. Modulation of the lipid binding properties of the N‐terminal domain of human apolipoprotein E3
    Paul M.M. Weers, Vasanthy Narayanaswami, Robert O. Ryan · 2001 · European Journal of Biochemistry
  87. Cyp46 (24S-Cholesterol Hydroxylase)
    Benjamin L. Wolozin · 2003 · Archives of Neurology
  88. Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat
    Karen J. Horsburgh, Michael Owen Fitzpatrick, Margaret Nilsen, James A. R. Nicoll · 1997 · Brain Research
  89. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.
    Veinbergs, Isaac, Mallory, Margaret, Mante, Michael, Rockenstein, Edward, Gilbert, John R, Masliah, Eliezer · 1999 · Neuroscience Letters
  90. Statins: drugs for Alzheimer’s disease?
    Eckert, G. P., Wood, W. G., Müller, W. E. · 2005 · Journal of Neural Transmission
  91. ApoE ɛ4 Genotype Is Accompanied by Lower Metabolic Activity in Nucleus Basalis of Meynert Neurons in Alzheimer Patients and Controls as Indicated by the Size of the Golgi Apparatus
    E.J.G. Dubelaar, Ronald W. H. Verwer, Michel A. Hofman, Joop J. van Heerikhuize, Rivka Ravid, Dick Frans Swaab · 2004 · Journal of Neuropathology & Experimental Neurology
  92. Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice
    Isaac Veinbergs, Min Whan Jung, Steve J Young, Emily Van Uden, Philip M. Groves, Eliezer Masliah · 1998 · Neuroscience Letters
  93. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes
    Anne‐Lie Svensson, Ulrika Warpman Berglund, Ewa Hellström‐Lindahl, Nenad Bogdanović, Lars Lannfelt, Agneta K. Nordberg · 1997 · Neuroscience Letters
  94. Benzodiazepine tolerance at GABAergic synapses on hippocampal CA1 pyramidal cells
    Xu J. Zeng, Elizabeth I. Tietz · 1999 · Synapse
  95. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.
    R W Mahley · 1996 · PubMed
  96. Engineering Conformational Destabilization into Mouse Apolipoprotein E
    Danny M. Hatters, Clare A. Peters-Libeu, Karl Heinrich Weisgraber · 2005 · Journal of Biological Chemistry
  97. Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence
    Jessica Drury, Vasanthy Narayanaswami · 2005 · Journal of Biological Chemistry
  98. Molecular Determinants of the Interaction Between the C‐Terminal Domain of Alzheimer's β‐Amyloid Peptide and Apolipoprotein E α‐Helices
    Laurence Lins, Annick Thomas‐Soumarmon, Thierry Pillot, Joel S. Vandekerckhove, Maryvonne Rosseneu, Robert Brasseur · 1999 · Journal of Neurochemistry
  99. Alzheimer s disease and heparan sulfate proteoglycan
    Ken-ichiro Fukuchi · 1998 · Frontiers in bioscience
  100. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease
    Jody Corey‐Bloom, Pietro Tiraboschi, L A Hansen, Michael F. Alford, B. Schoos, Marwan Noel Sabbagh, Eliezer Masliah, Leon J. Thal · 2000 · Neurology
  101. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
    Paul M.M. Weers, Vasanthy Narayanaswami, Nicole Choy, Robert Luty, Les D. Hicks, Cyril M. Kay, Robert O. Ryan · 2002 · Biophysical Chemistry
  102. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.
    Lary C. Walker, C A Parker, William J. Lipinski, Michael J. Callahan, R T Carroll, Sam Gandy, Jonathan D. Smith, Mathias Jucker, C L Bisgaier · 1997 · Europe PMC (PubMed Central)
  103. Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice
    S Chapman, Tonia Sabo, Allen D. Roses, Danny M. Michaelson · 2000 · Neuroscience
  104. Synaptic alterations in apolipoprotein E knockout mice
    Isaac Veinbergs, Eliezer Masliah · 1999 · Neuroscience
  105. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons
    Gong, Jian-Sheng, Morita, Shin-ya, Kobayashi, Mariko, Handa, Tetsurou, Fujita, Shinobu C, Yanagisawa, Katsuhiko, Michikawa, Makoto · 2007 · Molecular Neurodegeneration
  106. Contribution of Cysteine 158, the Glycosylation Site Theonine 194, the Amino- and Carboxy-Terminal Domains of Apolipoprotein E in the Binding to Amyloid Peptide β (1−40)
    Sergei B. Aleshkov, Xiaoping Li, Sophia N. Lavrentiadou, Vassilis I. Zannis · 1999 · Biochemistry
  107. Progress Toward Identification of Protease Activity Involved in Proteolysis of Apolipoprotein E in Human Brain
    Marques, Marcos A., Owens, Phillip A., Crutcher, Keith A. · 2004 · Journal of Molecular Neuroscience
  108. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
    Makoto Michikawa · 2006 · Acta Neurologica Scandinavica
  109. Kinetics of apolipoprotein E isoforms‐binding to the major glycosaminoglycans of the extracellular matrix
    Shuvaev, Vladimir V, Laffont, Isabelle, Siest, Gérard · 1999 · FEBS Letters
  110. Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice
    T. A. Robertson, Nichole Dutton, Ralph Nigel Martins, Allen D. Roses, Byron A. Kakulas, J. M. Papadimitriou · 1997 · Neuroscience
  111. No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice
    Francisca C. Bronfman, Ina C. Tesseur, Marten H. Hofker, L.M Havekens, Fred VAN LEUVEN · 2000 · Neuroscience
  112. A 13 kDa carboxy‐terminal fragment of ApoE stabilizes Abeta hexamers
    Sabine Wellnitz, Arno Friedlein, Corinne Bonanni, Vivianne Anquez, Fabienne Goepfert, Hansruedi Loetscher, Céline Adessi, Christian Czech · 2005 · Journal of Neurochemistry
  113. Sodium Dodecyl Sulfate-Resistant Complexes of Alzheimer’s Amyloid β-Peptide with the N-Terminal, Receptor Binding Domain of Apolipoprotein E
    Adam A. Golabek, Elizabeth Kida, Marius Walus, Christian Perez, Thomas Wısnıewskı, Claudio A. Soto · 2000 · Biophysical Journal
  114. Cholesterol's Role in Synapse Formation
    Alexei R. Koudinov, Natalia V. Koudinova · 2002 · Science
  115. Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid β peptide (1-42) interaction
    Mai-Jane Phu, Sharon K. Hawbecker, Vasanthy Narayanaswami · 2005 · Journal of Neuroscience Research
  116. Age-related Alterations of Apolipoprotein E and Interleukin-1β in the Aging Brain
    Jillian R. Gee, Qunxing Ding, Jeffrey N. Keller · 2006 · Biogerontology
  117. Heparin specifically inhibits binding of apolipoprotein E to amyloid β-peptide
    Vladimir V. Shuvaev, Gérard Siest · 2000 · Neuroscience Letters
  118. Apolipoprotein E deficiency effects on learning in mice are dependent upon the background strain
    Chris E. Lominska, Justine A. Levin-Allerhand, Jennifer Wang, John L. Sikes, Catherine Kao, Jonathan D. Smith · 2001 · Behavioural Brain Research
  119. Cholesterol-Lowering Drugs And Alzheimer’S Disease
    Gunter Peter Eckert, Walter E Müller, Gibson W. Wood · 2007 · Future Lipidology
  120. Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects
    Katsunori Ikewaki, Loren A. Zech, H Bryan Brewer, Daniel James Rader · 2002 · Journal of Laboratory and Clinical Medicine
  121. Modulation of apolipoprotein E and interleukin-1β in the aging liver
    Jillian R. Gee, Qunxing Ding, Jeffrey N. Keller · 2005 · Experimental Gerontology
  122. Apolipoprotein E and Alzheimer's Disease
    Warren J. Strittmatter · 2000 · Annals of the New York Academy of Sciences
  123. Apolipoprotein E-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion
    Jukka T. Puoliväli, Riitta A. Miettinen, Laurent Pradier, Paavo J. Riekkinen · 2000 · Neuroscience
  124. Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
    Daniela Fenili, JoAnne McLaurin · 2005 · CNS & Neurological Disorders - Drug Targets
  125. Cholesterol, Statins, and Alzheimer Disease
    Alexei R. Koudinov, Temirbolat T. Berezov · 2005 · PLoS Medicine
  126. [Apolipoprotein B immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in senile dementia of Alzheimer type].
    Y Namba, K Ikeda · 1991 · PubMed
  127. Untitled work
    Cole · 2000 · 10.1002/1097-0029(20000815)50:4
  128. Untitled work
    Jonnal · 2000 · 10.1002/1096-8628(20001204)96:6